University of Maryland BioPark

Featured BioPark Tenant

Fyodor Biotechnologies Inc.

Founded in 2008, Fyodor Biotechnologies, Inc. is a privately held, socially-responsible company that is developing innovative diagnostic and biopharmaceutical products that address the need for high-quality and affordable tools and medicines to effectively diagnose and treat diseases with high prevalence in developing markets. Fyodor's flagship product is a urine malaria test that can be used... more

www.fyodorbio.com
443-552-0437

Featured BioPark Building

MD Proton Treatment Center

The Maryland Proton Treatment Center ("MPTC") will be a state of the art, leading edge cancer center that will bring a highly advanced form of cancer treatment available today - proton therapy -to Baltimore, the State of Maryland, Washington, DC, Delaware and Northern Virginia. This center will feature five treatment rooms housed in an 110,000 square-foot facility in the University of Maryland BioPark on the University of Maryland, Baltimore campus. This cutting edge outpatient facility will also feature ground floor retail and includes space for research and training. The Maryland Proton Treatment Center is expected to begin treating patients in 2015.

View More Info »

Upcoming Events